U.S. Markets open in 8 hrs, 29 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,433.71 | -17.24 | -0.16% |
| NASDAQ | 2,169.18 | -6.83 | -0.31% |
| S&P 500 | 1,105.65 | -0.59 | -0.05% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 4.19 09:53 AM EST | |
|---|---|---|
| Day High | 4.40 09:30 AM EST |
|
| Range | 0.21 |
| Volume | 81,751 | |
|---|---|---|
| 30-Day Avg Vol | 143,000 |
|
| Difference | -42.83% |
| Market Cap | 144.43 M | |
|---|---|---|
| Mkt Cap Chg | -332,804 |
| Shares Out | 33.28 M | |
|---|---|---|
| % Shrs Traded | 0.25% | |
| 1yr EPS Est | -0.027 |
| 52-Wk Low | 0.41 | |
|---|---|---|
| 52-Wk High | 6.83 |
|
| Range | 6.42 |
| Prev Close | 4.35 11/23/09 | |
|---|---|---|
| Today's Open | 4.40 | |
| Change | 1.15% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 1.47 M |
| Revenue (LFY) | 83.07 M | |
|---|---|---|
| Earnings (LFY) | -30.67 M | |
| Earnings (MRQ) | -917,000.00 | |
| Next Earn Est | -0.007 | |
| Next Earnings | 02/15/2010 |
|
| EPS (TTM) | -1.78 | |
| 1yr EPS Growth | 89.62% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -16.00 | |
| PEG Ratio | -0.64 | |
| Return on Equity | -296.83 | |
| Beta | 0.72 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
ISTA Pharmaceuticals has set its sights on treating eye diseases. Through a collaboration with Japanese drug company Senju Pharmaceuticals, ISTA makes and sells Istalol (a glaucoma treatment) and Xibrom ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.0070 2/15/10 | — — |
—
—
|
| Last Quarter | -0.01 9/30/09 | 0.07 9/30/09 |
0.08
Beat
|
| 2 Quarters Ago | -0.09 6/30/09 | -0.08 6/30/09 |
0.01
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 32.00 M | 83.08 M |
| Gross Profit | 24.69 M | 61.13 M |
| Operating Income | 5.25 M | -24.81 M |
| Net Income | -917,000.00 | -30.67 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts